Thus, neonatal screening for GCDH deficiency is a reliable method for the detection of presymptomatic patients, and it enables the early detection and preemptive management of affected newborns (Greenberg et al. 2002; Kolker et al. 2006). This evidence concerns the gene GCDH and hyperinsulinemic hypoglycemia, familial, 4.